Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Na, A T"'
Publikováno v:
Global Journal of Environmental Science & Management (GJESM); Autumn2024, Vol. 10 Issue 4, p1859-1876, 18p
Publikováno v:
In Materials Today Physics March 2018 4:58-63
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Thomas, W., Phochantachinda, S., Buddhirongawat, R., Wilainam, W., Suwannaprapha, P., Issarangkul NA Ayutthaya, T., Wilainam, P.
Publikováno v:
In Journal of Comparative Pathology May 2023 203:82-82
Autor:
Photcharatinnakorn, P., Wilainam, W., Suwannaprapha, P., Issarangkul NA Ayutthaya, T., Wilainam, P.
Publikováno v:
In Journal of Comparative Pathology May 2023 203:82-82
Background: Maintenance therapy following autologous stem cell transplantation (ASCT) can delay disease progression and prolong survival in patients with multiple myeloma. Ixazomib is ideally suited for maintenance therapy given its convenient once-w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::7a2acf7f9477bb9d6fa6364f70564f15
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106326
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106326
Publikováno v:
Nature Communications, volume 9, Article number: 4101
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=r3c4b2081b22::f0cacf82412c0f18c57d0f26b07125bd
Panobinostat in combination with bortezomib and dexamethasone demonstrated a significant and clinically meaningful progression-free survival benefit compared with placebo, bortezomib and dexamethasone in the phase 3 PANORAMA 1 (Panobinostat Oral in M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::9aceb5310effeaaa51772b450f989cf2
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3108296
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3108296
Panobinostat is a potent pan-deacetylase inhibitor that affects the growth and survival of multiple myeloma (MM) cells through alteration of epigenetic mechanisms and protein metabolism. Panobinostat plus bortezomib and dexamethasone (PAN-BTZ-Dex) le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::de83bb13f333ecf36ccfab3d4a2c8675
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3001521
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3001521
Knowledge of human pancreas development underpins our interpretation and exploitation of human pluripotent stem cell (PSC) differentiation toward a β-cell fate. However, almost no information exists on the early events of human pancreatic specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2295::63fa390f3c1645b9151335f2aa1568f1